Kowa Of Japan Joining Crowded U.S. Statin Market With Partner Lilly
This article was originally published in PharmAsia News
Executive Summary
Japan's Kowa is set to enter the crowded U.S. market for cholesterol statins with its Livalo (pitavastatin) by partnering with Eli Lilly